{"altmetric_id":3558885,"counts":{"readers":{"mendeley":15,"citeulike":0,"connotea":0},"total":{"posts_count":1},"wikipedia":{"unique_users_count":1,"unique_users":["en:16854471"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa4eb3cf058f610002836","doi":"10.1038\/sj.ejhg.5200362","first_seen_on":"2015-02-12T22:56:36+00:00","issns":["1018-4813"],"journal":"European Journal of Human Genetics","last_mentioned_on":1207787717,"links":["http:\/\/dx.doi.org\/10.1038\/sj.ejhg.5200362","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10482951"],"pubdate":"1999-08-31T00:00:00+00:00","publisher":"Nature Publishing Group","publisher_subjects":[{"name":"Genetics","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["geneticsmedical"],"title":"A previously unrecognised phenotype characterised by obesity, muscular hypotonia, and ability to speak in patients with Angelman syndrome caused by an imprinting defect.","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/previously-unrecognised-phenotype-characterised-obesity-muscular-hypotonia-ability-speak-patients-an"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":3634360,"mean":4.9196455088828,"rank":815905,"this_scored_higher_than_pct":63,"this_scored_higher_than":2296024,"rank_type":"exact","sample_size":3634360,"percentile":63},"similar_age_3m":{"total_number_of_other_articles":96221,"mean":8.2505776553732,"rank":25170,"this_scored_higher_than_pct":72,"this_scored_higher_than":69945,"rank_type":"exact","sample_size":96221,"percentile":72},"this_journal":{"total_number_of_other_articles":1254,"mean":5.4218802873105,"rank":447,"this_scored_higher_than_pct":41,"this_scored_higher_than":518,"rank_type":"exact","sample_size":1254,"percentile":41},"similar_age_this_journal_3m":{"total_number_of_other_articles":76,"mean":15.342293333333,"rank":75,"this_scored_higher_than_pct":1,"this_scored_higher_than":1,"rank_type":"exact","sample_size":76,"percentile":1}}},"demographics":{"users":{"mendeley":{"by_status":{"Professor > Associate Professor":1,"Researcher":2,"Student  > Ph. D. Student":2,"Student  > Master":2,"Other":4,"Professor":4},"by_discipline":{"Medicine and Dentistry":6,"Social Sciences":1,"Physics and Astronomy":1,"Agricultural and Biological Sciences":5,"Biochemistry, Genetics and Molecular Biology":1,"Unspecified":1}}},"geo":{"mendeley":{"IS":1,"IN":1}}},"posts":{"wikipedia":[{"title":"ATP10A","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=204583256#altmetric_citation_8","license":"public","citation_ids":[3558885],"posted_on":"2008-04-10T00:35:17+00:00","summary":"Probable phospholipid-transporting ATPase VA also known as ATPase class V type 10A (ATP10A) or aminophospholipid translocase VA is an enzyme that in humans is encoded by the ATP10A gene.","page_url":"http:\/\/en.wikipedia.org\/?curid=16854471","wiki_lang":"en","author":{"name":"ProteinBoxBot","url":"http:\/\/en.wikipedia.org\/wiki\/User:ProteinBoxBot"}}]}}